ImmunityBio IBRX Stock
ImmunityBio Price Chart
ImmunityBio IBRX Financial and Trading Overview
| ImmunityBio stock price | 2.47 USD |
| Previous Close | 2.87 USD |
| Open | 2.85 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 2200 |
| Day's Range | 2.78 - 2.91 USD |
| 52 Week Range | 1.21 - 7.8 USD |
| Volume | 2.44M USD |
| Avg. Volume | 5.67M USD |
| Market Cap | 1.22B USD |
| Beta (5Y Monthly) | -0.337748 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.62 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.5 USD |
IBRX Valuation Measures
| Enterprise Value | 1.89B USD |
| Trailing P/E | N/A |
| Forward P/E | -3.361446 |
| PEG Ratio (5 yr expected) | 1.78 |
| Price/Sales (ttm) | 2075.7646 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3223.764 |
| Enterprise Value/EBITDA | -5.438 |
Trading Information
ImmunityBio Stock Price History
| Beta (5Y Monthly) | -0.337748 |
| 52-Week Change | -11.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.8 USD |
| 52 Week Low | 1.21 USD |
| 50-Day Moving Average | 2.89 USD |
| 200-Day Moving Average | 4.01 USD |
IBRX Share Statistics
| Avg. Volume (3 month) | 5.67M USD |
| Avg. Daily Volume (10-Days) | 3.21M USD |
| Shares Outstanding | 435.98M |
| Float | 122.45M |
| Short Ratio | 2.89 |
| % Held by Insiders | 72.70% |
| % Held by Institutions | 12.72% |
| Shares Short | 22.39M |
| Short % of Float | 20.53% |
| Short % of Shares Outstanding | 5.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -62504.44% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -62.46% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 586K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 2471.39% |
| Gross Profit (ttm) | 240K USD |
| EBITDA | -347424992 USD |
| Net Income Avi to Common (ttm) | -430084000 USD |
| Diluted EPS (ttm) | -1.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 91.27M USD |
| Total Cash Per Share (mrq) | 0.21 USD |
| Total Debt (mrq) | 766.73M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.201 |
| Book Value Per Share (mrq) | -1.213 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -346888992 USD |
| Levered Free Cash Flow (ttm) | -244396128 USD |
Profile of ImmunityBio
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3530 John Hopkins Court |
| ZIP | 92121 |
| Phone | 858 633 0300 |
| Website | https://immunitybio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 703 |
ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases in the United States and Europe. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion protein N-803, vaccine technologies, toll-Like receptor activating adjuvants, natural killer cells, and damage-associated molecular patterns inducers. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute and Amyris, Inc.; and license agreements with LadRx Corporation, GlobeImmune, Inc., Access to Advanced Health Institute, 3M Innovative Properties Company, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company is based in San Diego, California.
Q&A For ImmunityBio Stock
What is a current IBRX stock price?
ImmunityBio IBRX stock price today per share is 2.47 USD.
How to purchase ImmunityBio stock?
You can buy IBRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmunityBio?
The stock symbol or ticker of ImmunityBio is IBRX.
Which industry does the ImmunityBio company belong to?
The ImmunityBio industry is Biotechnology.
How many shares does ImmunityBio have in circulation?
The max supply of ImmunityBio shares is 882.47M.
What is ImmunityBio Price to Earnings Ratio (PE Ratio)?
ImmunityBio PE Ratio is now.
What was ImmunityBio earnings per share over the trailing 12 months (TTM)?
ImmunityBio EPS is -0.62 USD over the trailing 12 months.
Which sector does the ImmunityBio company belong to?
The ImmunityBio sector is Healthcare.
ImmunityBio IBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16286.45 USD — |
-0.13
|
6.42B USD — | 16181.17 USD — | 16408.51 USD — | — - | 6.42B USD — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2649.11 USD — |
+0.52
|
— — | 2632.15 USD — | 2665.49 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3968.91 USD — |
+0.94
|
— — | 3921.4 USD — | 3977.14 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 887.09 USD — |
+0.53
|
— — | 878.38 USD — | 889.86 USD — | — - | — — |
| Horizon Kinetics ISE Wealth Ind RCH | 2940.64 USD — |
+1.27
|
— — | 2913.34 USD — | 2956.41 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7964.03 USD — |
-0.14
|
— — | 7912.92 USD — | 8024.61 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 3927.42 USD — |
-1.76
|
— — | 3927.42 USD — | 3997.71 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1985.75 USD — |
+0.96
|
— — | 1964.36 USD — | 1992.16 USD — | — - | — — |
- {{ link.label }} {{link}}